Answers are grounded in this paper and cite their sources.
Snakebite envenoming remains a significant public health concern in rural sub-Saharan Africa, where limited access to antivenom and formal healthcare services contributes to the continued use of traditional plant-based remedies. However, ethnobotanical knowledge of these remedies remains poorly documented in parts of Nigeria, including Kogi State. This study documented medicinal plants traditionally used for snakebite management and their reported antiparasitic applications in selected communities of Kogi State, Nigeria. A cross-sectional ethnobotanical survey was conducted among 30 purposively and snowball-sampled respondents, comprising traditional healers, herbalists, hunters, and farmers across nine Local Government Areas: Idah, Ankpa, Okene, Adavi, Ibaji, Ofu, Olamaboro, Igalamela-Odolu, and Okehi. Data were collected using a structured interviewer-administered questionnaire and analyzed using descriptive statistics and ethnobotanical indices. Twenty medicinal plant species belonging to 16 families were documented, with Annonaceae, Anacardiaceae, Fabaceae, and Meliaceae being the most represented families. Leaves were the most frequently used plant part (40.0%), while decoction was the predominant preparation method (33.3%). Malaria was the most frequently reported antiparasitic application (43.3%), followed by intestinal helminth infections (26.7%). Perceived efficacy was high, with 46.7% of respondents rating the remedies as very effective and 33.3% as moderately effective. A total of 94 use reports yielded an informant consensus factor (ICF) of 0.80, while Azadirachta indica was the most frequently cited species (16 use reports). The findings provide baseline ethnobotanical information on plants used for snakebite management in Kogi State and highlight recurring traditional applications of some species for both snakebite and parasitic infections, particularly malaria. The documented plants warrant further phytochemical, toxicological, and pharmacological investigation to evaluate their therapeutic potential and safety.
No takes yet. Share an insight, caveat, or question.
Linus et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: